Early Continuous Ultrafiltration in Chinese Patients with Congestive Heart Failure (EUC-CHF): Study Protocol for an Open-Label Registry-Based Prospective Clinical Trial

Pp to 30% of the patients with decompensated HF (NYHA classification III to IV) present with LDs resistance.

Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study

Patients with Multisite artery disease (MSAD) are regularly encountered in clinical practice and their prognosis is poorer than that of patients with just one territory affected.

Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 Single-Arm Clinical Trial

Global estimates show that a large proportion of society worldwide (31% of adults) had Stage 2 hypertension (>140/90 mmHg) in 2010.

Prevalence and Risk Factors for Dyslipidemia among Adults in Rural and Urban China: Findings from the China National Stroke Screening and Prevention Project (CNSSPP)

Lipid abnormalities are associated with an increased risk of CV events including coronary heart disease (CHD), thereby serving as contributors to this process.

Advanced Heart Failure Therapies for Adults with Congenital Heart Disease: JACC State-of-the-Art Review

In the contemporary era, nearly 85% of children with congenital heart disease will reach adulthood.

Factors Influencing Subclinical Atherosclerosis in Patients with Biopsy-Proven Non-alcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease, with a worldwide prevalence of approximately 25%.